Paul V Maier's Net Worth
Estimate Recalculated Nov 1, 2024 10:49AM EST
Who is Paul V Maier
Paul V Maier does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include International Stem Cell CORP, RITTER PHARMACEUTICALS INC, Eton Pharmaceuticals, Inc., PURE BIOSCIENCE, APRICUS BIOSCIENCES, INC., MABVAX THERAPEUTICS HOLDINGS, INC., Ambrx Biopharma Inc., SEQUENOM INC, Hana Biosciences Inc, and Ambrx Biopharma, Inc..
SEC CIK
Paul V Maier's CIK is 0001182615
Past Insider Trading and Trends
2016 was Paul V Maier's most active year for acquiring shares with 13 total transactions. Paul V Maier's most active month to acquire stocks was the month of May. 2013 was Paul V Maier's most active year for disposing of shares, totalling 8 transactions. Paul V Maier's most active month to dispose stocks was the month of June. 2017 saw Paul V Maier paying a total of $135,258.00 for 254,969 shares, this is the most they've acquired in one year. In 2018 Paul V Maier cashed out on 136,474 shares for a total of $30,299.79, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
